Adage Capital Partners
KMTS icon

Adage Capital Partners’s Kestra Medical Technologies KMTS Stock Holding History

Adage Capital Partners’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.54M Buy
+100,000
New +$2.09M ﹤0.01% 859
2025
Q2 		– Sell
-100,000
Closed -$2.49M – 970
2025
Q1 		$2.49M Buy
+100,000
New +$2.3M ﹤0.01% 751

Other funds holding KMTS

Bain Capital Investors
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Adage Capital Partners's KMTS Position: Q2 2026 in Review

Adage Capital Partners opened a new position in Kestra Medical Technologies (KMTS) in Q2 2026: 100,000 shares worth $2.54M. The stake represents ﹤0.01% of the portfolio and ranks #859 among its holdings. This is a return to the name: Adage Capital Partners previously reported a position in KMTS as recently as Q1 2025.

Adage Capital Partners first reported a position in KMTS in Q1 2025 and has held it in 2 quarters since. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Adage Capital Partners held 100,000 shares of Kestra Medical Technologies worth $2.54M as of Q2 2026.
  • Kestra Medical Technologies was a new Adage Capital Partners position in Q2 2026.
  • Kestra Medical Technologies made up ﹤0.01% of Adage Capital Partners's portfolio in Q2 2026, its #859 holding.
  • Adage Capital Partners first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 2 quarters since.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.